The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 44 articles
A new resorbable magnesium scaffold for de novo coronary lesions, the DREAMS 3G: one-year results of the BIOMAG-1 first-in-human study
Haude M,
Wlodarczak A,
van der Schaaf RJ,
Torzewski J,
Ferdinande B,
Escaned J,
Iglesias JF,
Bennett J,
Toth G,
Joner M,
Toelg R,
Wiemer M,
Olivecrano G,
Vermeersch P,
Garcia-Garcia H,
Waksman R
May 17, 2023 | 10.4244/EIJ-D-23-00326
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
Slagboom T,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematus M,
Takahashi A,
Waksman R,
Saito S
February 20, 2023 | 10.4244/EIJ-D-22-00526
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
January 13, 2023 | 10.4244/EIJ-D-22-00718
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G,
Soria Jimenez CE,
Torguson R,
Case BC,
Forrestal B,
Ali S,
Shea C,
Zhang C,
Wang J,
Gordon P,
Ehsan A,
Wilson SR,
Levitt R,
Parikh P,
Bilfinger T,
Hanna N,
Buchbinder M,
Asch F,
Weissman G,
Shults C,
Garcia-Garcia H,
Ben-Dor I,
Satler L,
Waksman R,
Rogers T
August 5, 2022 | 10.4244/EIJ-D-21-01091
Scaffold thrombosis: what is to blame?
December 17, 2021 | 10.4244/EIJV17I12A159
High bleeding risk patients: one size does not fit all
June 25, 2021 | 10.4244/EIJV17I3A35
Entrapment of the Impella heart pump in the mitral subvalvular apparatus
February 5, 2021 | 10.4244/EIJ-D-19-00942
Adverse events with orbital atherectomy: an analytic review of the MAUDE database
Khalid N,
Javed H,
Rogers T,
Hashim H,
Shlofmitz E,
Wermers J,
Chen Y,
Musallam A,
Khan J,
Torguson R,
Bernardo N,
Waksman R
July 17, 2020 | 10.4244/EIJ-D-19-00295
Bioresorbable scaffolds: did we jump the gun?
June 12, 2020 | 10.4244/EIJV16I2A16
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M,
Ince H,
Toelg R,
Lemos P,
von Birgelen C,
Christiansen E,
Wijns W,
Neumann F,
Eeckhout E,
Garcia-Garcia H,
Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Reply to the letter to the editor “Impella device use in high-risk PCI”
October 18, 2019 | 10.4244/EIJ-D-19-00279R
Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model
Lipinski M,
Acampado E,
Cheng Q,
Adams L,
Torii S,
Gai J,
Torguson R,
Hellinga DG,
Joner M,
Harder C,
Zumstein P,
Finn A,
Kolodgie F,
Virmani R,
Waksman R
January 18, 2019 | 10.4244/EIJ-D-17-00958
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023